Historique
Rapport
An overview of cannabis potency in Europe
(Panorama du potentiel addictif du cannabis en Europe)
Auteur(s) :
KING, L. ;
CARPENTIER, C. ;
GRIFFITHS, P.
Année
2004
Page(s) :
71 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
;
Luxembourg : Office for Official Publications of the European Communities
Collection :
Insights, n°6
ISBN :
978-92-9168-184-9
Refs biblio. :
73
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
TETRAHYDROCANNABINOL
;
CANNABIS
;
CANNABINOIDES
;
PHARMACOLOGIE
;
TRAFIC
;
TOXICITE
Thésaurus géographique
EUROPE
Résumé :
ENGLISH :
Cannabis is the illegal substance most commonly used in all countries of the European Union. The increased use of cannabis during the past decade has increased the profile of the drug. Used mainly by young adults, but also by many schoolchildren, cannabis is a drug consumed by individuals during their formative years, at a time when they may be more vulnerable to the long-term harmful effects of drug use. Comments in the media and elsewhere of a large increase in the potency of cannabis have raised concerns that the drug now available is much stronger than that available in the past.
To establish a scientific basis on which to advise policymakers and practitioners in the drugs field, the EMCDDA commissioned an investigation into cannabis potency in Europe. The results of this study are presented here. [Editor's abstract]
Cannabis is the illegal substance most commonly used in all countries of the European Union. The increased use of cannabis during the past decade has increased the profile of the drug. Used mainly by young adults, but also by many schoolchildren, cannabis is a drug consumed by individuals during their formative years, at a time when they may be more vulnerable to the long-term harmful effects of drug use. Comments in the media and elsewhere of a large increase in the potency of cannabis have raised concerns that the drug now available is much stronger than that available in the past.
To establish a scientific basis on which to advise policymakers and practitioners in the drugs field, the EMCDDA commissioned an investigation into cannabis potency in Europe. The results of this study are presented here. [Editor's abstract]
Affiliation :
Portugal